BULLISH Option Flow >$1M doesn't stop at $IBM

3:27 PM

$PENN moved into Target 2 and we trimmed exposure while keeping the trade on watch 📈

3:21 PM

The $MOD setup reached Target 1. We trimmed the position and kept the remaining exposure under review ✅

1:46 PM

The $ADSK setup reached Target 1. We trimmed the position and kept the remaining exposure under review ✅

12:31 PM

$ZETA moved into Target 2 and we trimmed exposure while keeping the trade on watch 🎯

11:17 AM

$SPY supports to kick off the week. A move above 760.00 is needed for a squeeze up. Buyers need a close above 754.69 today. to maintain the overnight uptrend.

10:58 AM

$ARKG just broke into three year highs last week. Big movement in gene editing recently...might be a wave of buyers coming to the industry

10:48 AM

$IBM pushed into Target 1, giving us room to trim exposure while keeping the rest under review 📈

10:47 AM

⚠ BREAKING: US ISM Manufacturing PMI Actual 54 (Forecast 53, Previous 52.7)

10:37 AM

The $DXCM setup reached Target 2. We trimmed the position and kept the remaining exposure under review 🎯

10:06 AM

Opened a new long position in •••• as the setup turned active 🚀

10:06 AM

Opened a new long position in •••• as the setup came into play 🚀

9:51 AM

$NVDA is underperforming all major chip designers YTD. Yet, it has the highest 3-year growth expectation after $AVGO.

9:42 AM

Closed •••• here after the setup played out, booking profit 🔔

9:41 AM

$ZETA got to Target 1. Trimmed there, still watching the rest ✅

9:32 AM

Good morning team!

8:41 AM

DexCom Inc (DXCM)

May 17, 2026

← Back to Research

3 min read

Key performance indicators that once lived only in clinical settings are migrating into everyday life. Continuous glucose monitoring has become a wearable health trend, and the combination of sensor hardware and smartphone ecosystems is encouraging broader consumer engagement. These devices transmit glucose readings to apps and can alert users to extremes in glucose, creating real time metabolic feedback that appeals to both people with diabetes and a wider audience pursuing metabolic mastery. The sector dynamic now includes consumer wellness adoption alongside clinical usage.

Trade Setup

Ticker DXCM

Price

Support

Target 1

Target 2

Progress

Related Research

Can the Market Sustain Its Rally as FOMC Approaches May 31, 2026 S&P 500 Weekly Market and Technical Update May 31, 2026 Stock Market Opportunities for June May 31, 2026 Modine Manufacturing Co. (MOD) May 31, 2026 AutoDesk (ADSK) May 31, 2026

← Back to Research